HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL

HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL

Sipariş numarası: P2279.9501

Shipping: Shipment: not cooled. Store at -20°C. For laboratory usage only!

Teslim süresi yaklaşık. 5 iş günü

Miktar Birim fiyatı
Hedef 2 149,35 € *
Kaynak 3 119,48 € *


Please select the favoured pack size.


Please select the favoured purity.

T cell epitopes are presented on the surface of antigen-presenting cells by MHC molecules. T... daha fazla
Ürün bilgileri "HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL"

T cell epitopes are presented on the surface of antigen-presenting cells by MHC molecules. T cell epitopes presented by MHC class I molecules are typically peptides between 8 and 11 amino acids in length and exhibiting MHC-specific sequence motifs

Results of B. Vali et al. We identified a relatively high degree of amino acid sequence similarity between HLA-A2-restricted epitopes HIV (HXB2) gag: 77-85 (SLYNTVATL: SL9) and HCV (H77) NS5b:2594-2602 (ALYDVVSKL: AL9). Of the screened HIV-infected individuals, 5 subjects showed significant response to both peptides. PBMCs from these individuals were used for tetramer analysis. Among the examined responders, three individuals showed CD8+ T-cells distinctly double-stained for both tetramers. Flow cytometry was conducted for expression analysis of IFN-g and the degranulation marker CD107a on PBMCs stained with SL9 tetramer and stimulated with either SL9 or AL9 peptides ... .

Conclusions: The preliminary findings of the group indicate a potential T-cell cross-recognition between HIV derived HLA-A2 restricted SLYNTVATL and HCV derived HLA-A2 restricted ALYDVVSKL epitopes. This degeneracy of HIV-specific T-cells may play a role in the underlying immunological mechanisms related to pathological profile of HCV/HIV co-infection and variable clinical outcomes influenced by different CD8 T-cell repertoire.

İlgili bağlantılar "HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL"
Specifications: Purity: >95% (HPLC) Sequence: ALYDVVTKL HLA-type: HLA-A*02:01 lyophilized... daha fazla

Technische Daten:

Purity: >95% (HPLC)
HLA-type: HLA-A*02:01
lyophilized white powder



Sicherheits Hinweise / Safety

Klassifizierungen / Classification

eclass-Nr: 32-16-04-09
Dokumente - Protokolle - Downloads daha fazla

Dokumente - Protokolle - Downloads

Hier finden Sie Informationen und weiterführende Literatur zu HCV NS5B (2594-2602) HLA-A*02:01 ALYDVVTKL. Für weitere Dokumente (Zertifikate mit weiteren Lotnummern, Sicherheitsdatenblätter in anderer Sprache, weitere Produktinformationen) wenden Sie sich bitte an Genaxxon biosience unter: info@genaxxon.com oder Tel.: +49 731 3608 123.

CMV IE-1 (199-207) - ELRRKMMYM CMV IE-1 (199-207) - ELRRKMMYM
Gönderen 72,00 € * 90,00 € *
Melan-A / MART-1 (26-35) - EAAGIGILTY - B*35:01 Melan-A / MART-1 (26-35) - EAAGIGILTY - B*35:01
Gönderen 80,00 € * 100,00 € *
[Leu27] - Melan-A / MART-1 (26-35) - ELAGIGILTV [Leu27] - Melan-A / MART-1 (26-35) - ELAGIGILTV
Gönderen 74,16 € * 92,70 € *